The Global Pharmaceuticals sector witnessed 4 Mergers & Acquisitions deals in July 2022, for an aggregate deal value of $1,439.4 million. This represents a decrease of 82.9% in terms of value and a decrease of 55.0% in terms of volume, year over year.
A total of 87 Mergers & Acquisitions deals were recorded over the last twelve months (LTM) for an aggregate deal value of $67,835.6 million. In the LTM period, September 2021, turned out to be the most prolific in terms of deal size, with a total deal value of $3,739.1 million and a deal volume of 10 during that month. On the other hand, the month of November 2021, was the most prolific in terms of deal volume, recording a total of 13 deals with a total deal value of $6,161.3 million during that month.
On an average, over the LTM period, 7 deals were done with an average deal size of $5,653.0 million.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer